SpringWorks Therapeutics Inc. (SWTX) options active on 61K contracts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Barclays Downgrades Spring Works Therapeutics (SWTX) to Equalweight
April 28, 2025 9:29 AM EDTBarclays analyst Peter Lawson downgraded Spring Works Therapeutics (NASDAQ: SWTX) from Overweight to Equalweight with a price target of $47.00 (from $63.00).
For an analyst ratings summary and ratings history on Spring Works Therapeutics... More



